GxP Quality Management Software: A Single Validated Platform for GMP, GCP, GLP, GDP, and GPvP Quality and Training Records

GxP compliance software is a validated quality management platform built to manage quality records and training records across the Good Practice frameworks that govern pharmaceutical and life sciences organizations. GxP — an umbrella term for the family of Good Practice quality standards — is not a single regulation. Each framework in the GxP family governs a different segment of the regulated value chain: Good Manufacturing Practice for manufacturing, Good Clinical Practice for clinical trials, Good Laboratory Practice for non-clinical safety studies, Good Distribution Practice for pharmaceutical supply chain, and Good Pharmacovigilance Practice for post-market safety monitoring. An organization that manufactures a drug product, runs clinical trials, operates a non-clinical testing laboratory, distributes through a cold-chain network, and monitors post-market safety reports is operating under multiple GxP frameworks simultaneously — each with its own quality system requirements and its own mandatory training obligations.

The question that brings quality professionals to this page is operational: what software system can manage quality records and training records across multiple GxP frameworks, satisfy the 21 CFR Part 11 validation requirement that applies to any computer system used for GxP records, and do it in a single platform rather than a collection of separately validated point solutions? eLeaP is that platform. This page covers the five GxP frameworks, what validated GxP quality management software requires, and how eLeaP delivers across all five.

The GxP Umbrella: Five Frameworks, Five Sets of Quality System Requirements

GxP stands for Good (x) Practice, where x identifies the practice domain. Each framework governs a specific regulated activity and imposes specific quality system and training requirements on organizations conducting that activity.

GMP — Good Manufacturing Practice

Good Manufacturing Practice governs the manufacture of pharmaceutical products, biological products, and medical devices. In the United States, the current GMP frameworks are 21 CFR Parts 210 and 211 for finished pharmaceuticals, the 600 series for biological products, and the Quality Management System Regulation (QMSR, effective February 2, 2026) for medical devices — which incorporates ISO 13485:2016 by reference and supersedes the prior 21 CFR Part 820 framework. In Europe, GMP is defined by EU GMP Parts I and II and a series of technical annexes. GMP quality system requirements include batch production records, deviation management, CAPA, change control, equipment qualification, process validation, and document control. GMP training is required by 21 CFR Part 211.25 for pharmaceutical manufacturing personnel, which mandates that each person engaged in the manufacture, processing, packing, or holding of a drug product have the education, training, and experience to perform their assigned functions.

GCP — Good Clinical Practice

Good Clinical Practice governs the conduct of clinical trials involving human subjects. The international standard is ICH E6(R3), adopted by FDA, EMA, and health authorities across major regulated markets. GCP quality system requirements include protocol deviation management, investigator site oversight, informed consent documentation, essential documents management, and audit trails for clinical data. GCP training requirements under ICH E6(R3) Annex 1, Section 2.1 (Qualifications and training) mandate that investigators and trial staff be qualified by education, training, and experience to perform their respective tasks, with training records maintained and available for inspection by the sponsor and by regulatory authorities.

GLP — Good Laboratory Practice

Good Laboratory Practice governs non-clinical safety studies conducted to support regulatory submissions. In the United States, GLP is defined by 21 CFR Part 58. Internationally, the OECD GLP principles apply. GLP quality system requirements include study plan and protocol control, raw data integrity, specimen management, equipment calibration and maintenance records, and quality assurance unit independence and oversight. GLP training requirements mandate that all personnel involved in the conduct of a study have the education, training, and experience to perform their assigned functions, with training records available for inspection. The quality assurance unit must verify that personnel are properly trained for their assigned functions.

GDP — Good Distribution Practice

Good Distribution Practice governs the storage and distribution of pharmaceutical products, ensuring that product quality is maintained throughout the supply chain from manufacturer to end user. In Europe, GDP is defined by the EU GDP Guidelines 2013/C 343/01. In the United States, the FDA’s drug supply chain security requirements under the Drug Supply Chain Security Act impose equivalent obligations. GDP quality system requirements include temperature-monitored storage, transportation qualification, distributor qualification, complaint handling for distribution-related quality events, and recall management. GDP training requirements mandate that distribution personnel are trained on the procedures governing the activities they perform, with training records maintained.

GPvP — Good Pharmacovigilance Practice

Good Pharmacovigilance Practice governs the safety monitoring of medicinal products after approval and during clinical development. In Europe, GPvP is defined by EU Good Vigilance Practice (GVP) Modules published by EMA. In the United States, the FDA’s pharmacovigilance system requirements under 21 CFR Parts 312 and 314 apply. GPvP quality system requirements include individual case safety report management, signal detection procedures, periodic safety update report preparation, risk management plan maintenance, and audit of pharmacovigilance system compliance. GPvP training requirements mandate that pharmacovigilance personnel are trained on the procedures governing their safety monitoring functions, with training records available for GPvP audits.

The Validated System Requirement: What It Means and Who Is Responsible for What

Any computer system used to create, modify, maintain, archive, retrieve, or transmit records required by GxP regulations must be validated before it is used for those purposes. This is the fundamental requirement of 21 CFR Part 11 for FDA-regulated activities and EU Annex 11 for European GxP activities. The validation requirement applies to the GxP quality management software itself, not just to the manufacturing or laboratory systems it manages. A QMS platform used to manage GMP batch records, GCP protocol deviation records, or GLP study documentation is a GxP-applicable computerized system and must be validated accordingly.

Validation responsibility is shared between the software vendor and the regulated user. The distinction matters: misunderstanding it leads organizations to either over-rely on vendor documentation and skip required customer validation activities, or to over-invest in validation work the vendor has already completed.

What eLeaP Provides in Its GxP Validation Support Package

Installation Qualification (IQ): protocol and report confirming the system was correctly installed in the hosted environment and that the hosting infrastructure meets the defined specifications.

Operational Qualification (OQ): protocol covering core system functions against documented functional specifications, demonstrating that the system performs its intended functions correctly under expected operating conditions.

System design documentation: data flow diagrams, architecture documentation, and security configuration documentation supporting the customer’s risk assessment and validation planning.

Change notification documentation: advance notification of system changes with impact assessment documentation, supporting the customer’s change control obligation for maintaining a validated state.

21 CFR Part 11 compliance documentation: mapping of Part 11 requirements to the system capabilities that address them, supporting the customer’s Part 11 assessment.

What the Customer Is Responsible For

Performance Qualification (PQ): executing tests that demonstrate the system performs correctly in the customer’s specific configured environment, for the customer’s specific intended uses and workflows.

Validation summary report: the documented conclusion that the system is suitable for its intended use in GxP applications, signed by the customer’s quality unit.

Ongoing validation maintenance: assessing eLeaP system updates against the validated state, executing regression testing where required, and updating the validation documentation to reflect approved changes.

User access management: maintaining user accounts, role assignments, and access controls consistent with the validated configuration and the GxP responsibilities of each user.

GAMP 5 and Risk-Based Validation

GAMP 5 (Good Automated Manufacturing Practice, Second Edition), published by ISPE, provides the globally accepted risk-based framework for computerized system validation in GxP environments. GAMP 5 classifies software into categories based on the nature of the software and the degree of configuration required, with Category 4 applying to configured software products — the category that applies to a platform such as eLeaP where the core software is vendor-supplied but the workflows, record structures, and access configurations are customer-configured. A Category 4 validation approach focuses validation effort on the customer’s specific configuration and intended use rather than re-testing vendor-supplied infrastructure that the vendor has already qualified. eLeaP’s validation support package is designed to support a GAMP 5 risk-based validation approach: the IQ and OQ documentation address the vendor-qualified infrastructure; the customer’s PQ and validation summary address the configured environment and intended use. Customers should confirm with their quality unit whether their organization applies GAMP 5 categorization in their computerized system validation procedures and align the validation approach accordingly.

How eLeaP Delivers GxP Quality Management Software Compliance: Four System Capabilities

GxP quality management software compliance is not a marketing claim. It is a set of specific system capabilities that must be present, configured correctly, and validated. eLeaP delivers each of the following capabilities as native platform architecture, not as optional add-ons or integrations that introduce additional validation complexity.

21 CFR Part 11 Audit Trail

21 CFR Part 11 requires that computerized systems maintain secure, computer-generated, time-stamped audit trails that independently record the date and time of operator entries and actions that create, modify, or delete electronic records. The audit trail must be available for review and copying by the FDA. In eLeaP, the audit trail captures every record creation, modification, and deletion with the operator’s unique identifier, the date and time of the action, and the specific change made. The audit trail is tamper-evident: it cannot be modified or deleted by any user through the application interface, and system roles are procedurally and architecturally restricted from altering system logs to preserve full data integrity. The audit trail covers all GxP-applicable records in the system — quality records, training records, document revisions, workflow actions, and system configuration changes.

Role-Based Access Controls

21 CFR Part 11 requires that system access be limited to authorized individuals and that the system use operational system checks to enforce permitted sequencing of steps. GxP organizations require access controls that reflect the GxP responsibilities of each role: a GCP clinical data manager should not have write access to GMP manufacturing records, and a GMP production operator should not have access to GCP investigator site records. eLeaP’s role-based access configuration applies access at the record type, workflow stage, and organizational unit level. Access configuration is maintained in the system’s validated configuration, and changes to access assignments are captured in the audit trail. Periodic access review is supported by a system report showing all users, their assigned roles, and their access permissions at the time of the report.

Electronic Signatures with Part 11 Compliance

21 CFR Part 11 requires that electronic signatures be unique to one individual, not reused or reassigned to another individual, and bound to their respective electronic records so that the signatures cannot be excised, copied, or otherwise transferred to falsify a record. eLeaP’s electronic signatures are securely and permanently bound to their respective electronic records within the database architecture, ensuring that any subsequent modification to the signed record is automatically flagged and tracked by the audit trail. Each signature requires the signer’s unique identification code and a confirmation password at the time of signing — the two identification components required by Part 11. The signature record captures the signer’s identity, the date and time, and the meaning of the signature as defined in the workflow configuration.

System Change Control Procedures

Maintaining a validated state requires that changes to the GxP quality management software — configuration changes, workflow changes, user role changes, and platform updates from eLeaP — are assessed for impact on the validated state and implemented through a documented change control process. eLeaP provides advance notification of platform updates with change assessment documentation that supports the customer’s impact evaluation. The customer’s change control procedure for system changes requires documenting the change, assessing its impact on the validated state, executing any required regression testing, updating the validation documentation, and obtaining quality unit approval before the change is effective in the GxP environment.

GxP Training Management: The Requirement Across Every Good Practice Framework

Training is a regulatory requirement under every GxP framework, not a best practice. GMP training is required by 21 CFR Part 211.25 for pharmaceutical manufacturing personnel. GCP training is required by ICH E6(R3) Annex 1, Section 2.1, which mandates that investigators and trial staff be qualified by education, training, and experience to perform their respective tasks. GLP training is required by 21 CFR Part 58.29, which mandates that all personnel involved in the conduct of a study have the education, training, and experience to perform their assigned functions. GDP training is required by EU GDP Guidelines Section 2.4. GPvP training is required under the EU GVP Module I requirements for pharmacovigilance system staffing. Each framework requires not only that training occur but that training records be maintained and available for inspection or audit.

The training management challenge in a multi-GxP organization is that each framework imposes training requirements specific to the activities it governs. A GMP production operator’s training matrix covers GMP SOPs, validated processes, and GMP regulatory qualification. A GCP clinical research associate’s training matrix covers ICH E6(R3), protocol-specific training, and therapeutic area qualifications. A GLP study director’s training matrix covers OECD GLP principles, study plan review procedures, and study conduct qualifications. Maintaining these separate training profiles in a system that is also managing the quality records those procedures govern requires either a single integrated QMS and LMS or a separately validated LMS connected to the QMS through a data interface that introduces additional validation complexity and additional validation scope.

eLeaP manages both GxP quality records and GxP training records in a single validated system. The QMS and LMS share the same platform, the same database, the same audit trail, and the same Part 11 compliance architecture. A GxP inspector who wants to see a specific employee’s training records alongside the quality records for the activities that employee performed views both within the same integrated platform under a unified audit trail architecture — without cross-system reconciliation, API dependency, or separate validation scope for the training system.

When a GxP procedure is revised — whether it is a GMP SOP, a GCP protocol, a GLP study plan procedure, or a GDP distribution procedure — eLeaP automatically identifies every role assigned to that procedure in the training matrix and creates retraining assignments for every person in those roles. The training assignment carries the procedure version number. Completion records link to the specific version. A GxP inspector asking whether personnel were trained on the version of a procedure in effect on a specific date receives an immediate, reconciled view directly from the system without manual assembly across separate software solutions.

Evaluating GxP Quality Management Software: Five Questions That Establish Fitness for Purpose

GxP quality management software must satisfy the regulatory requirements of each GxP framework the organization operates under, the 21 CFR Part 11 and EU Annex 11 validated system requirements, and the practical operational requirements of managing quality and training records across multiple practice domains. The questions below test fitness for purpose across all three dimensions.

Question 1: Does the Platform Support Configurable Workflows for Each GxP Framework?

Does the platform support configurable quality system workflows for each GxP framework — GMP batch records and deviation management, GCP protocol deviation and site oversight, GLP study plan control and quality assurance audit — or does it apply a single quality record template to all GxP activity types? Each GxP framework has structurally distinct documentation requirements. A platform that forces GMP batch records and GCP protocol deviations into the same record template is not configured for GxP compliance — it is a generic quality record system with GxP terminology applied. Framework-specific workflow configuration is a baseline capability requirement, not a premium feature.

Question 2: Does the Validation Support Package Cover Part 11 and Annex 11?

Does the validation support package include IQ and OQ protocol templates with traceability to 21 CFR Part 11 and EU Annex 11 requirements, and does the vendor provide advance notification of system changes with impact assessment documentation for the customer’s change control evaluation? The validation support package is part of the platform’s compliance infrastructure. A vendor that does not provide IQ and OQ documentation, Part 11 compliance mapping, and change impact assessment documentation is transferring validation burden to the customer that should sit with the vendor.

Question 3: Does the Audit Trail Cover All GxP-Applicable Records with Tamper-Evident Protection?

Does the 21 CFR Part 11 audit trail cover all GxP-applicable records in the system — quality records, training records, document revisions, workflow actions, and configuration changes — with tamper-evident records that cannot be modified or deleted through the application interface by any user? An audit trail that covers quality records but not training records, or that covers records but not configuration changes, is incomplete for GxP compliance. The tamper-evident requirement means the audit trail architecture must prevent modification through the application at any user privilege level — not just restrict it through access controls that can be reconfigured.

Question 4: Are QMS and LMS on the Same Platform and the Same Validated System?

Are the QMS and LMS on the same platform and the same validated system, so that GxP training records and GxP quality records share the same audit trail and Part 11 compliance architecture — without a separate validated LMS or an API integration that introduces additional validation scope? A separately validated LMS connected to the QMS through an API creates two validation scopes, two audit trails, and a reconciliation requirement between systems every time a GxP inspector asks to see quality and training records together. The integrated architecture is not a convenience feature — it is a compliance architecture difference that affects validation scope, audit trail coverage, and inspection readiness.

Question 5: Does a GxP Procedure Revision Automatically Generate Version-Current Training Assignments?

When a GxP procedure is revised, does the system automatically generate training assignments for all affected roles with the procedure version captured in the completion record — so that version-current training is demonstrable from the system without manual reconciliation? This is the training compliance question that applies equally across GMP, GCP, GLP, and GDP frameworks. In each framework, the inspection-readiness requirement is the same: demonstrate that the personnel performing a regulated activity on a specific date were trained on the version of the procedure that was current on that date. A system that requires manual reconciliation between training records and document version history to answer that question is producing a compliance gap proportional to the volume of procedure revisions.

eLeaP’s answers to all five questions are yes, demonstrable in a scoped GxP platform walkthrough configured for the buyer’s primary practice domain. The demonstration covers the quality record and training record architecture for GMP, GCP, or GLP as applicable, the audit trail and electronic signature demonstration, and the validation support package overview. Request a scoped GxP demonstration at eleapsoftware.com.

Frequently Asked Questions: GxP Compliance Software

What does GxP mean and which regulations does it cover?

GxP is an abbreviation for Good (x) Practice, where x identifies the specific practice domain. The GxP family covers five primary frameworks in pharmaceutical and life sciences: GMP (Good Manufacturing Practice), governing drug, biologics, and medical device manufacturing; GCP (Good Clinical Practice), governing clinical trial conduct under ICH E6(R3); GLP (Good Laboratory Practice), governing non-clinical safety studies under 21 CFR Part 58 and OECD principles; GDP (Good Distribution Practice), governing pharmaceutical distribution under EU GDP Guidelines 2013/C 343/01; and GPvP (Good Pharmacovigilance Practice), governing post-market safety monitoring under EU GVP Modules. Each framework imposes independent quality system requirements and mandatory training documentation obligations.

What is GxP compliance software?

GxP compliance software is a validated quality management system built to manage quality records and training records across multiple GxP frameworks in a single platform. It differs from a generic QMS in three ways: it supports framework-specific workflow configurations for each GxP practice domain; it maintains the 21 CFR Part 11 and EU Annex 11 validated system architecture required for GxP electronic records; and it integrates quality and training record management in a single platform so that GxP inspectors can view quality records and training records together under the same audit trail without reconciliation between systems.

Why does GxP compliance software need to be validated?

Any computer system used to create, modify, maintain, archive, retrieve, or transmit records required by GxP regulations must be validated before use. This requirement is established by 21 CFR Part 11 for FDA-regulated GxP activities and EU Annex 11 for European GxP activities. The validation requirement applies to the GxP software itself — not just to manufacturing equipment or laboratory systems. A QMS used to manage GMP batch records, GCP protocol deviations, or GLP study documentation is a GxP-applicable computerized system. Validation demonstrates through documented testing that the system consistently performs its intended functions under intended operating conditions.

What is the difference between what the software vendor provides and what the customer must do for GxP validation?

Validation responsibility is shared. The vendor provides Installation Qualification (IQ) and Operational Qualification (OQ) documentation, system design and architecture documentation, 21 CFR Part 11 compliance mapping, and advance notification of system changes with impact assessment documentation. The customer is responsible for Performance Qualification (PQ) — testing the system in their specific configured environment for their specific intended uses — the validation summary report signed by the customer’s quality unit, ongoing validation maintenance as the system is updated, and user access management consistent with the validated configuration. Vendors who claim to provide “full validation” without customer PQ and validation summary obligations are misrepresenting the shared responsibility structure that 21 CFR Part 11 and EU Annex 11 establish.

Why does it matter whether the QMS and LMS are on the same validated platform?

When QMS and LMS are on separate platforms — even connected by an API — they have separate validation scopes, separate audit trails, and a reconciliation requirement between them. A GxP inspector asking to see a specific employee’s training records alongside the quality records for activities that employee performed requires cross-system reconciliation if the two record sets live in separate validated systems. If the API connecting the systems is unavailable or produces an inconsistency, the reconciliation fails during inspection. When QMS and LMS share the same platform, the same database, and the same audit trail, the inspector’s query returns both record sets from a single system under a single audit trail — no reconciliation, no API dependency, no separate validation scope for the training records.

What are the GxP training requirements and how do they differ across frameworks?

Every GxP framework requires that personnel performing regulated activities be qualified through education, training, and experience, and that training records be maintained and available for inspection. The specific citations are: 21 CFR Part 211.25 for GMP pharmaceutical manufacturing personnel; ICH E6(R3) Annex 1, Section 2.1 for GCP investigators and trial staff; 21 CFR Part 58.29 for GLP study personnel; EU GDP Guidelines Section 2.4 for GDP distribution personnel; and EU GVP Module I for GPvP pharmacovigilance personnel. The training management challenge across frameworks is that each imposes role-specific training requirements — a GMP production operator’s training matrix is structurally different from a GCP clinical research associate’s training matrix. A multi-GxP organization needs a training management system that can maintain framework-specific training matrices while sharing a common quality record architecture and audit trail.

What does 21 CFR Part 11 require for GxP electronic records and signatures?

21 CFR Part 11 establishes the requirements for electronic records and electronic signatures used in FDA-regulated GxP activities. For electronic records, Part 11 requires: secure, computer-generated, time-stamped audit trails that independently record operator actions creating, modifying, or deleting records; the ability to generate accurate and complete copies of records; protection of records to enable their accurate and ready retrieval throughout the records’ retention period; and use of validated systems. For electronic signatures, Part 11 requires: signatures that are unique to one individual and not reused or reassigned; signatures bound to their respective records so they cannot be excised, copied, or transferred; and signatures executed with at least two identification components — typically a unique ID and a password — at the time of signing. EU Annex 11 imposes equivalent requirements for European GxP activities.

What is the difference between GxP compliance software and a general QMS?

A general QMS manages quality records in configurable workflows. GxP compliance software manages quality records in framework-specific workflows that enforce the documentation standards and investigation structures that GxP regulations require — and does so in a validated system that satisfies 21 CFR Part 11 and EU Annex 11 requirements. The practical difference is visible at inspection: a general QMS produces records; a GxP compliance system produces audit-ready records with tamper-evident audit trails, electronic signatures bound to records, version-current training documentation, and framework-specific investigation workflows that an inspector can navigate without requiring manual assembly of evidence from multiple systems.

GxP Compliance Software: Terminology and Search Synonyms

GxP compliance software is referenced by several terms across regulatory guidance, industry publications, and quality management software categories. The following synonyms and related terms describe capabilities covered on this page.

GxP Quality Management Software / GxP QMS

GxP quality management software” and “GxP QMS” are direct synonyms for GxP compliance software, emphasizing the quality management system architecture that underlies GxP compliance. The functional scope is identical: validated quality record management across GMP, GCP, GLP, GDP, and GPvP frameworks with 21 CFR Part 11 compliance.

GxP Training Software / GxP Training Management

“GxP training software” and “GxP training management” refer specifically to the training record management capability within GxP compliance software — the framework-specific training matrices, version-current training assignment automation, and training-to-quality-record linkage that GxP training compliance requires. Standalone GxP training software that operates outside an integrated QMS requires separate validation, separate audit trail coverage, and manual reconciliation with quality records at inspection.

Life Sciences QMS / Life Sciences Compliance Software

“Life sciences QMS” and “life sciences compliance software” are category terms that encompass GxP compliance software along with the broader quality management needs of pharmaceutical, biotech, clinical, and medical device organizations. GxP compliance is the core requirement within the life sciences QMS category — the validated system, Part 11 architecture, and multi-framework support that distinguishes a life sciences platform from a general-purpose QMS.

21 CFR Part 11 Compliant QMS / Part 11 Quality Management Software

21 CFR Part 11 compliant QMS” and “Part 11 quality management software” refer to a QMS that satisfies the electronic records and electronic signatures requirements of 21 CFR Part 11 — the foundational validation and audit trail requirement that applies to all GxP quality management software used in FDA-regulated activities. Part 11 compliance is a necessary but not sufficient condition for GxP fitness: a platform can be Part 11 compliant without supporting the framework-specific workflow configurations that GMP, GCP, and GLP each require.

Validated QMS / Validated Quality Management System

“Validated QMS” and “validated quality management system” refer to a quality management platform that has been subjected to computerized system validation — IQ, OQ, and PQ — demonstrating it consistently performs its intended functions. For GxP organizations, software validation is a regulatory requirement. A validated QMS vendor provides IQ, OQ, and supporting documentation; the customer completes PQ and the validation summary report for their specific environment and intended uses.

GMP GCP GLP Software / Multi-Framework GxP Software

“GMP GCP GLP software” and “multi-framework GxP software” describe a platform that supports quality and training record management across more than one GxP practice domain in a single validated system. Organizations that operate across multiple GxP frameworks — a pharmaceutical company that also runs clinical development or a CDMO that supports multiple sponsor GxP environments — require a platform that maintains framework-specific configurations without requiring separately validated systems for each practice domain.

About eLeaP QMS

eLeaP is a quality management and learning management platform built by Telania, LLC, founded in 2002. The platform serves regulated-industry organizations across pharmaceutical manufacturing, medical device, biotechnology, CDMO/CRO, clinical operations, food and beverage, cannabis, and aerospace — industries that require a validated, Part 11-compliant QMS and LMS in a single integrated system. The core differentiator is native QMS+LMS integration: GxP procedure revisions automatically generate training assignments for affected roles, CAPA-triggered training enforces corrective action effectiveness, and the training gate mechanism prevents record closure until training completions are confirmed. eLeaP is designed for mid-market organizations (50–500 employees) operating under one or more GxP frameworks who require full compliance capability without enterprise implementation complexity.

Related resources:

• Pharmaceutical QMS Software — GMP quality system requirements
• Life Sciences QMS Software — multi-framework GxP quality management
• Computerized System Validation — GxP validated system requirements
• 21 CFR Part 11 Software — electronic records and signatures compliance